Patents
Sitemap › A01 - Agriculture; Forestry; Animal husbandry; Hunting; Trapping; Fishing › A01K - Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise provided for; New breeds of animals › A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals
Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
06/2003
06/26/2003US20030121067 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
06/26/2003US20030121066 Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
06/26/2003US20030121065 Polyfunctional base sequence and artificial gene containing the same
06/26/2003US20030121062 Transgenic organism
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119107 Prevent aggregation of embryos stem cells; controlling by encapsulation
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030118568 Viral stealth technology to prevent T cell-mediated rejection of xenografts
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2456210A1 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/25/2003EP1321476A2 Binding protein
06/25/2003EP1321034A1 Disruption of the phosphodieterase 10 gene
06/25/2003EP1321033A1 Transgenic expression of glycogen synthase kinase 3 in muscle
06/25/2003EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320597A2 Induction of exon skipping in eukaryotic cells
06/25/2003EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/25/2003EP1320292A2 Method of cloning porcine animals
06/25/2003EP0679182B1 Delivery of gene products via mesangial cells
06/25/2003EP0620849B1 Transgenic animal models for alzheimer's disease
06/25/2003CN2556930Y Disk cluster and cocoon releaser
06/25/2003CN1426478A Prion-free transgenic ungulates
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426466A Genetic silencing
06/25/2003CN1425764A In situ cancer cell cloning animal test research method
06/25/2003CN1425283A Rail duck raising technology in paddy field
06/24/2003US6583336 Generation of transgenic plant; obtain cells, incubate with expression vector, transform cells, recover transformed cells, propagate in nutrient broth
06/24/2003US6583334 Ovariectomized mouse model for human menopause
06/24/2003US6583333 Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas
06/24/2003US6583115 Methods for treating acromegaly and giantism with growth hormone antagonists
06/24/2003US6583112 Gene products related to werner's syndrome
06/24/2003US6582957 Lipoxygenase proteins and polynucleotides encoding the same
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences
06/19/2003WO2003050502A2 Prospective identification and characterization of breast cancer stem cells
06/19/2003WO2003050293A2 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003049768A1 Selective anesthetic agents and methods of identifying the same
06/19/2003WO2003049537A1 Method of preparing eggs for nuclear transfer and uses thereof
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003US20030115621 Detection of central nervous system disorders using tau protein
06/19/2003US20030115620 Major histocompatibility complex; transgenic swine
06/19/2003US20030115619 Animal with reduced sensitivity to disease
06/19/2003US20030115618 Method of generating a transgenic livestock animal
06/19/2003US20030115616 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity
06/19/2003US20030114378 Mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113338 Immunogenic detoxified mutant e. coli lt-a toxin
06/19/2003US20030113299 Isolated species of steinernematid nematode and methods of white grub control therewith
06/19/2003US20030111020 Culture of sessile marine animals
06/19/2003US20030111016 Methods for gamete production in birds
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469257A1 Method of preparing eggs for nuclear transfer and uses thereof
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319408A1 Remedies for heart failure
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/18/2003EP1319067A2 Human coagulation factor vii variants
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319015A2 Olfactory and pheromones g-protein coupled receptors
06/18/2003EP0638124B1 Oral infection of insect larvae with pre-occluded baculovirus particles
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425023A Transgenic mice containing TRP gene disruptions
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1423929A Culture of hiruto and extraction of hirutin
06/17/2003US6580017 Into a recipient mammal when it is in the 2 to 8 cell stage of embryogenesis; use to produce a cloned or transgenic mammal
06/17/2003US6579850 Polypeptide, novel DNA and novel antibody
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/13/2003CA2371460A1 Cell culture system and methods of use
06/12/2003WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048364A2 Ovomucoid promoter and methods of use
06/12/2003WO2003048356A1 Screening methods employing fish model assessment of vision
06/12/2003WO2003048346A1 Gene targeting methods and vectors
06/12/2003WO2003048338A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
06/12/2003WO2003048325A2 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047532A2 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
06/12/2003WO2003047336A2 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES
06/12/2003WO2003026399A3 Gng4 gene disruptions, compositions and methods related thereto
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030110524 Transgenic organisms and their uses
06/12/2003US20030110521 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription
06/12/2003US20030109683 Hybrid proteins; controlling gene expression in gene therapy; Parkinson's disease
06/12/2003US20030108914 Amplification of nucleic acids
06/12/2003US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 341